Nettet24. jul. 2024 · 3 Min Read. (Reuters) - U.S. Food and Drug Administration (FDA) scientists on Monday expressed concern that Intellipharmaceutics International Inc had failed to provide adequate data on the abuse ... Nettet21. jul. 2024 · Results of Operations The Company recorded net loss for the three months ended May 31, 2024 of $840,654 or $0.03 per common share, compared with a net …
IntelliPharmaCeutics International Aktie - FINANZEN.NET
NettetIntellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture... Nettet4. aug. 2024 · Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and … cavenaghi gravedona
Intellipharmaceutics: Fiscal Q4 Earnings Snapshot
Nettet1. mar. 2024 · Intellipharmaceutics: Fiscal Q4 Earnings Snapshot MarketScreener Homepage Equities Canada Toronto Stock Exchange Intellipharmaceutics International Inc. News Summary IPCI CA4581733090 INTELLIPHARMACEUTICS INTERNATIONAL INC. (IPCI) Add to my list Company Financials Funds Nettet8. feb. 2024 · Intellipharmaceutics Announces Delay in Filing Second Quarter Results Due July 15, 2024, The Financial Statements Will be Filed By July 21, 2024. … Nettet7. jan. 2013 · Intellipharmaceutics International Inc. 30 Worcester Road Toronto, ON Canada M9W 5X2 www.intellipharmaceutics.com Shameze Rampertab Vice President Finance & CFO 416-798-3001 x106 investors@ ... cavender\u0027s rock revival jeans